Jeffrey Mann - Embecta Corp General VP

EMBC Stock  USD 20.83  0.24  1.17%   

VP

Jeffrey Mann is General VP of Embecta Corp
Age 52
Address 300 Kimball Drive, Parsippany, NJ, United States, 07054
Phone862 401 0000
Webhttps://www.embecta.com

Embecta Corp Management Efficiency

The company has return on total asset (ROA) of 0.0964 % which means that it generated a profit of $0.0964 on every $100 spent on assets. This is way below average. Embecta Corp's management efficiency ratios could be used to measure how well Embecta Corp manages its routine affairs as well as how well it operates its assets and liabilities. As of December 1, 2024, Return On Tangible Assets is expected to decline to 0.06. In addition to that, Return On Capital Employed is expected to decline to 0.28. At present, Embecta Corp's Other Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Intangible Assets is expected to grow to about 10 M, whereas Total Assets are forecasted to decline to about 1.1 B.
Embecta Corp currently holds 1.64 B in liabilities. Embecta Corp has a current ratio of 2.49, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Embecta Corp's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Found 5 records

VP Age

Geeta KavetiNevro Corp
N/A
Geoffrey GillespieOrthofix Medical
N/A
Anthony DAdamioBioventus
63
Peter SocarrasNevro Corp
43
Anthony JDBioventus
63
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. operates independently of Becton, Dickinson and Company as of April 1, 2022. Embecta Corp operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 2000 people. Embecta Corp (EMBC) is traded on NASDAQ Exchange in USA. It is located in 300 Kimball Drive, Parsippany, NJ, United States, 07054 and employs 2,200 people. Embecta Corp is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Embecta Corp Leadership Team

Elected by the shareholders, the Embecta Corp's board of directors comprises two types of representatives: Embecta Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Embecta. The board's role is to monitor Embecta Corp's management team and ensure that shareholders' interests are well served. Embecta Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Embecta Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jeffrey Mann, General VP
Jean Casner, Senior Officer
Brian Capone, Chief VP
Slobodan Radumilo, Senior International
Devdatt Kurdikar, CEO President
Shaun Curtis, Senior Chain
Ginny Blocki, Senior Management
Tom Blount, Senior America
Ajay Kumar, VP Officer
Colleen Riley, Senior Officer
Pravesh Khandelwal, VP Relations
Jacob Elguicze, Senior CFO

Embecta Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Embecta Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Embecta Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Embecta Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Embecta Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Embecta Corp Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Embecta Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For information on how to trade Embecta Stock refer to our How to Trade Embecta Stock guide.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Embecta Corp. If investors know Embecta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Embecta Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.04)
Earnings Share
1.34
Revenue Per Share
19.438
Quarterly Revenue Growth
(0.05)
Return On Assets
0.0964
The market value of Embecta Corp is measured differently than its book value, which is the value of Embecta that is recorded on the company's balance sheet. Investors also form their own opinion of Embecta Corp's value that differs from its market value or its book value, called intrinsic value, which is Embecta Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Embecta Corp's market value can be influenced by many factors that don't directly affect Embecta Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Embecta Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Embecta Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Embecta Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.